In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...

A recent study released by the University of Wisconsin-Madison sheds light on how the sugary enhancer1 (se1) allele influences the nutritional profile ...

Douglas A. Tremblay, MD, discusses the long-term data supporting ropeginterferon alfa-2b-njft as treatment in patients with polycythemia vera.

INmune Bio (INMB) is presenting a poster at the annual International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic ...

Secondary endpoints in the MINDFuL trial include the CDR-SB, E-Cog, ADL and Neuropsychiatric Inventory (NPI) instruments, along with blood biomarker and neuroimaging outcomes. Baseline demographics, ...

RE:WIND is looking to bring the pop boy groups back to America. The three-member Asian American group made their debut with ...

In testing, adults with mild cognitive impairment score lower on a simple smell test than adults with normal cognitive ...

Stroke survivors who have some level of higher education could face more profound cognitive decline due to a stroke, ...

Wave Life Sciences Ltd.’s WVE share price has dipped by 10.08%, which has investors questioning if this is right time to buy.

Paraphrase in combination with HiFi long-read sequencing provides a single framework for resolving highly similar paralogous ...

Maze Therapeutics IPOs at $487M, targeting APOL1 Kidney Disease with MZE829 in Phase 2. Click here to read an analysis of MAZE stock now.